New data show a ‘clear and significant’ association between ambient air quality and respiratory issues in the first year of life. Continue Reading »

Half of patients with a false-positive test experienced unnecessary isolation. Continue Reading »

We recap last week's multiple RFK Jr testimonies, some potentially good news at the federal level, and state vaccine policy news. Continue Reading »

As early as 40 days after infection, no trace of SARS-CoV-2 was found in placentas from women who recovered from COVID-19. Continue Reading »

But it does reduce viral load and speed time to recovery. Continue Reading »

The decision comes after a positive phase 3 trial in older adults. Continue Reading »

The report was scheduled to be published in the CDC’s flagship publication on March 19. Continue Reading »

The measures may have long-term implications for future vaccine policy, the authors say. Continue Reading »

A large study in Germany shows lower hospitalization, all-cause death rates, and health care costs in vaccinated people. Continue Reading »

School-aged children with long COVID had more than double the risk of decreased academic performance than those without the condition.  Continue Reading »

Increased post-COVID risk was noted for pulmonary embolism, abnormal breathing, fatigue, hemorrhagic stroke, brain fog, and palpitations. Continue Reading »

The findings of the online survey highlight the challenge of effectively communicating the threat of AMR to the public and explaining how unnecessary antibiotic use makes the problem worse. Continue Reading »

An OECD report finds that long COVID continues to hinder workforce productivity.  Continue Reading »

Major structural birth defects were reported in 1% each of live births to mothers repeatedly vaccinated in their first trimester and those not revaccinated. Continue Reading »

So far this season, 139 children have died from the virus, and about 85% with a known vaccination status were unvaccinated.  Continue Reading »

The study also reveals that women with long COVID experience more heart problems than men.  Continue Reading »

The report was to be published on March 19, and showed people who had received an updated seasonal COVID vaccine reduced their likelihood of ED and urgent care visits by 50%. Continue Reading »

The study findings highlight the particularly devastating effects of COVID-19 on economically and socially vulnerable groups. Continue Reading »

A new study links post-COVID ocular symptoms such as blurred vision and dry eyes to worse overall health and greater socioeconomic challenges.  Continue Reading »

Researchers say the reduction was influenced by the combined effects of changes in infection prevention and control, antimicrobial stewardship, and health care delivery. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 April 2026, and includes updates on avian influenza, Salmonella Bovismorbificans, and an overview of respiratory virus epidemiology in the EU/EEA. Continue Reading »

Most respiratory virus activity remains low overall across the EU/EEA. RSV: moderate activity but decreasing, with the seasonal peak already passed in most countries. Influenza: activity has returned to inter-seasonal levels. COVID 19: Very low activity. Continue Reading »

Most respiratory virus activity remains low overall across the EU/EEA. Influenza has returned to inter-seasonal levels. COVID 19 circulation is also very low. RSV activity is elevated but decreasing. Peak levels having passed in most countries. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 April 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, measles, zika, and chikungunya. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 April 2026, and includes updates on avian influenza, dengue, and an overview of respiratory virus epidemiology in the EU/EEA. Continue Reading »

Most respiratory virus activity remains low overall across the EU/EEA. Influenza and COVID 19 circulation are low or continuing to decline. RSV activity remains elevated, with early indications of a gradual decline. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 March-3 April 2026 and includes updates on SARS-CoV-2 variant classification, Middle East respiratory syndrome coronavirus (MERS-CoV), cholera, HIV, and avian influenza. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21–27 March 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, chikungunya, dengue, avian influenza, invasive meningococcal disease, aedes aegypti detection in Luxembourg, and measles. ... Continue Reading »

This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2. Continue Reading »

Most respiratory viruses are declining across the EU/EEA: Influenza circulation and hospitalisations are decreasing. SARS CoV 2 activity is low. RSV activity remains elevated, with children under five years the most affected. Continue Reading »